ESC 22: Hot Line & Late-breaking Science Video Collection
Published: 24 August 2022
-
Views:
6349
-
Likes:
7
-
Views:
6349
-
Likes:
7
-
5m 34sPart 4 | Session 1 ASCEND: Aspirin and Omega-3 Fatty Acids in Preventing Heart Failure -
2m 29sPart 4 | Session 2 ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease
-
7m 9s
-
4m 22sPart 4 | Session 4 PACIFIC-AMI: Asundexian on Top of DAPT After Acute Myocardial Infarction
-
6m 28s
-
6m 26s
-
3m 45sPart 4 | Session 7 Artificial Intelligence Detection of Severe Aortic Stenosis
-
7m 25sPart 4 | Session 8 MOMENTUM 3: 5-year Results From HeartMate 3 LVAD Therapy
-
4m 13sPart 4 | Session 9 MASTER DAPT Results at 15M with Prof Valgimigli
-
3m 57sPart 4 | Session 10 APOLLO: Apixaban for Prevention of Thromboembolic Outcomes in COVID
-
3m 22sPart 4 | Session 11 The PRE18FFIR Trial: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI
-
5m 44sPart 4 | Session 12 FIDELITY: Finerenone in Pts With Chronic Kidney Disease
-
4m 44sPart 4 | Session 13 The EMPEROR-POOLED Trial: Clinical Benefits of SGLT2i in Heart Failure
-
2m 55sPart 4 | Session 14 The EMMY Trial: Empagliflozin in Patients with Acute MI
-
4m 51sPart 4 | Session 15 COVID-PACT: Antithrombotic Therapy in Critically Ill COVID-19 Pts
-
4m 59sPart 4 | Session 16 ACT: Anti-Coronavirus Therapies to Prevent Progression of COVID-19
-
5m 51sPart 4 | Session 17 PERSPECTIVE: Sacubitril/Valsartan & Cognitive Function in HFmrEF & HFpEF
-
1m 29sPart 5 | Session 1 Behind the Heart: Michelle Goonasekera
-
1m 15sPart 5 | Session 2 Behind the Heart: Isla S Mackenzie
-
6m 28sPart 5 | Session 3 Behind the Heart: Douglas Bradley
-
2m 20sPart 5 | Session 4 Behind the Heart: Ashkan Shoamanesh
-
1m 22sPart 5 | Session 5 Behind the Heart: Mukul Sharma
-
1m 18sPart 5 | Session 6 Behind the Heart: Geoffrey Strange
-
4m 30sPart 5 | Session 7 Behind the Heart: Martha Gulati
-
1m 50sPart 5 | Session 8 Behind the Heart: John H Alexander
-
1m 54sPart 5 | Session 9 Behind the Heart: Renato D Lopes
-
1m 16sPart 5 | Session 10 Behind the Heart: David Newby
-
1m 43sPart 5 | Session 11 Behind the Heart: Faiez Zannad
-
1m 8sPart 5 | Session 12 Behind the Heart: Harald Sourij
-
2m 2sPart 5 | Session 13 Behind the Heart: David Berg
-
1m 11sPart 5 | Session 14 Behind the Heart: Sanjit Jolly
-
1m 20sPart 5 | Session 15 Behind the Heart: Mirvat Alasnag
-
4m 30sPart 5 | Session 16 Behind the Heart: Martha Gulati
-
2m 33sPart 5 | Session 17 Behind the Heart: Purvi Parwani
-
2m 51sPart 5 | Session 18 Behind the Heart: John McMurray
-
59sPart 5 | Session 19 Behind the Heart: Marco Valgimigli
-
6m 50sPart 6 | Session 1 REVIVED-BCIS2, RTC, FRAME-AMI by Dr Mirvat Alasnag
-
9m 51sPart 6 | Session 2 DANCAVAS, DELIVER, SECURE by Dr Purvi Parwani
-
3m 29sPart 6 | Session 3 eBRAVE-AF, CAPLA, INVICTUS by Dr Afzal Sohaib
-
7m 2sPart 6 | Session 4 TIME, SECURE, DANCAVAS by Dr Martha Gulati
-
33m 19sPart 1 | Session 1 View from the Thoraxcenter – ESC 2022 Wrap Up Nicolas M Van Mieghem, Joost Daemen
-
24m 27sPart 1 | Session 2 View from the Thoraxcenter – ESC 2022 Preview Nicolas M Van Mieghem, Joost Daemen
-
17m 13sPart 2 | Session 1 Late-breaker Discussion: The INVICTUS Trial Harriette Van Spall, Ganesan Karthikeyan
-
11m 27sPart 2 | Session 2 Late-breaker Discussion: The DELIVER Trial Harriette Van Spall, Scott Solomon
-
14m 31sPart 2 | Session 3 Late-breaker Discussion: The REVIVED Trial Harriette Van Spall, Divaka Perera
-
11m 5sPart 2 | Session 4 Late-breaker Discussion: The ADVOR Trial Wilfried Mullens, Harriette Van Spall
Overview
What's hot at European Society of Cardiology (ESC) Congress 22?
Stay tuned and browse our curated coverage of the latest data in cardiology.
- For a concise line up of the most awaited trials join Prof Nicolas Van Mieghem and Dr Joost Daemen and their regular View From the Thoraxcenter series.
- For a deeper dive into key clinical trial data and applicability, host, Dr Harriette Van Spall talks with principal investigators in her Late-Breaker Discussion Series.
- Short, accessible Expert Interviews conducted with select faculty focusing on data, patient care and the future of their field.
- To mark the release of the new ESC Guidelines on Cardio-Oncology, we will feature a 10-minute summary and a 10-minute live audience Q&A.
- We asked some of the most prominent researchers today about their pathways in the Behind the Heart series.
Watch our Radcliffe Premiere TV to be transported to Barcelona.
More from this programme
Part 1
View From the Thoraxcenter: Review Series
Part 2
Late-breaker Discussion Series With Dr Harriette Van Spall
Part 3
ESC Guidelines on Cardio-Oncology: Summary & Question Time
Part 4
Hot Line & Late-breaking Interviews
Part 5
Behind the Heart from Barcelona
Part 6
3 Trials That Will Change Your Practice: Reviews
Faculty Biographies
Teresa López Fernández
Consultant Cardiologist
Prof Teresa López Fernández is a clinical investigator and consultant cardiologist at La Paz University Hospital in Madrid, ES. She specialises in cardiac imaging (she is board certified in advanced and transesophageal echocardiography by the European Society of Cardiology (ESC)) and cardio-oncology (she is board certified by the International Cardio-Oncology Society), and currently coordinates the cardio-oncology team at La Paz University Hospital. She is the founder and chair of the Spanish Cardio-Oncology Working Group at the Spanish Society of Cardiology (SEC) and the Secretary of the ESC Council of Cardio-Oncology.
Alexander Lyon
Consultant Cardiologist
Dr Alexander Lyon is a leading London-based consultant cardiologist, specialising in the field of heart failure, cardiomyopathy, cardio-oncology and takotsubo syndrome. He is highly experienced, and is well-versed in all aspects of cardiology. Along with his private clinics at Royal Brompton Hospital and in central London, he is also senior lecturer for the National Heart and Lung Institute at Imperial College London.
Dr Lyon graduated with a first class degree from Oxford University, and gained experience doing post-graduate training in London and Sydney before setting up private practice in London. His clinical interests are in the field of heart failure, chemotherapy cardiomyopathy and Takotsubo cardiomyopathy, and he is the theme leader for heart failure research in the NIHR-funded Biomedical Research Unit at the Royal Brompton Hospital.
Arjun K Ghosh
Dr Arjun Ghosh MBBS, MSc, PhD, FHEA, FACC, FESC, FRCP, FICOS is a Consultant Cardiologist at University College London Hospital (UCLH) and Barts Heart Centre, London, UK.
He helped establish and grow cardio-oncology services at UCLH and Barts Heart Centre which are now amongst the biggest in the world. He is the clinical lead of the UCLH service which looks after all the cardiac needs of cancer patients and also has national and international cardio-oncology leadership roles with the British Cardio-Oncology Society and the International Cardio-Oncology Society. Arjun was also joint first author of the UK’s first cardio-oncology guideline.